ES2111002T3 - Factor activador de macrofagos derivado de la proteina de fijacion de vitamina d. - Google Patents

Factor activador de macrofagos derivado de la proteina de fijacion de vitamina d.

Info

Publication number
ES2111002T3
ES2111002T3 ES91917591T ES91917591T ES2111002T3 ES 2111002 T3 ES2111002 T3 ES 2111002T3 ES 91917591 T ES91917591 T ES 91917591T ES 91917591 T ES91917591 T ES 91917591T ES 2111002 T3 ES2111002 T3 ES 2111002T3
Authority
ES
Spain
Prior art keywords
macrophagus
vitamin
activating factor
factor derived
fixation protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917591T
Other languages
English (en)
Inventor
Nobuto Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2111002T3 publication Critical patent/ES2111002T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTA UN NUEVO Y POTENTE FACTOR DE ACTIVACION DE MACROFAGOS QUE SE PREPARA IN VITRO TRATANDO UN COMPONENTE ESPECIFICO DEL GRUPO HUMANO, TAMBIEN CONOCIDO COMO PROTEINA DE UNION DE LA VITAMINA D HUMANA, CON GLICOSIDASAS. EL COMPONENTE ESPECIFICO DE GRUPO, QUE SE AISLA A PARTIR DE LA SANGRE OBTENIDA POR PROCEDIMIENTOS CONOCIDOS, SE CONVIERTE DE ESTA FORMA EN UN FACTOR ACTIVADOR DE MACROFAGOS ALTAMENTE POTENTES.
ES91917591T 1990-08-31 1991-08-29 Factor activador de macrofagos derivado de la proteina de fijacion de vitamina d. Expired - Lifetime ES2111002T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/576,248 US5177002A (en) 1989-11-20 1990-08-31 In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor

Publications (1)

Publication Number Publication Date
ES2111002T3 true ES2111002T3 (es) 1998-03-01

Family

ID=24303582

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917591T Expired - Lifetime ES2111002T3 (es) 1990-08-31 1991-08-29 Factor activador de macrofagos derivado de la proteina de fijacion de vitamina d.

Country Status (9)

Country Link
US (1) US5177002A (es)
EP (1) EP0546096B1 (es)
JP (1) JP2596491B2 (es)
AT (1) ATE161580T1 (es)
AU (1) AU8654191A (es)
CA (1) CA2092720C (es)
DE (1) DE69128535T2 (es)
ES (1) ES2111002T3 (es)
WO (1) WO1992004459A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177001A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor
US5326749A (en) * 1989-11-20 1994-07-05 Nobuto Yamamoto Macrophage activating factor from vitamin D binding protein
US5627029A (en) * 1991-05-03 1997-05-06 Genzyme Corporation Method for obtaining informative cells
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
AU6137801A (en) * 2000-05-09 2001-11-20 Childrens Medical Center Method and composition for the treatment of angiogenesis
DE60226327T2 (de) * 2001-08-14 2009-07-09 Statens Serum Institut Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin
EP2612921B1 (en) * 2010-09-03 2016-11-02 Morita Pharmaceutical Ind., Ltd. Method for production of novel degalactosylated gc globulin
CA2832487A1 (en) 2011-04-07 2012-10-11 Efranat Ltd. Macrophage activating factor for pharmaceutical compositions
ES2805795T3 (es) * 2012-09-28 2021-02-15 Ellis Kline Régimen de glicosidasa para el tratamiento de enfermedades infecciosas
CN105530950A (zh) * 2013-06-09 2016-04-27 艾弗兰纳特有限公司 包含Gc-巨噬细胞活化因子的组合物及其用途
US20210198307A1 (en) * 2017-12-15 2021-07-01 Foundation For Biomedical Research And Innovation At Kobe Method for producing active gcmaf

Also Published As

Publication number Publication date
EP0546096A1 (en) 1993-06-16
DE69128535T2 (de) 1998-05-20
AU8654191A (en) 1992-03-30
ATE161580T1 (de) 1998-01-15
CA2092720A1 (en) 1992-03-01
DE69128535D1 (de) 1998-02-05
EP0546096B1 (en) 1997-12-29
US5177002A (en) 1993-01-05
WO1992004459A1 (en) 1992-03-19
JP2596491B2 (ja) 1997-04-02
JPH06503716A (ja) 1994-04-28
EP0546096A4 (es) 1994-04-27
CA2092720C (en) 1999-12-14

Similar Documents

Publication Publication Date Title
ES2111002T3 (es) Factor activador de macrofagos derivado de la proteina de fijacion de vitamina d.
ES2120416T3 (es) Inhibidores del crecimiento tumoral derivados de tejidos, metodos de preparacion y usos de dichos inhibidores.
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
BG99605A (en) Antagonists of the growth factor or endothelial cells of the circulatory system
MX162688A (es) Suturas compuestas de seda y elastomeros termoplasticos hidrofobos
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
SG170730A1 (en) Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
DK0429570T3 (da) Osteoinducerende præparater
NL300353I1 (nl) Geneesmiddelen met monoclonale antilichamen, die specifiek zijn voor de menselijk epidermale groeifactorreceptor
DK275482A (da) Medicinske klaebeark til behandling af hjertesygdomme samt fremgangsmaade til fremstilling deraf
HK1048831A1 (en) Human ctla-4 antibodies and their uses
DE60020529D1 (de) Antikörper zur krebsbehandlung und -diagnose
DK0396387T3 (da) Nyt antistoffremføringssystem for modifikatorer for biologisk respons
CY1108765T1 (el) ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
NO883306D0 (no) Farmasoeytisk aktive konjugater med forbedret bindingsspesifisitet for kroppsvev.
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
ES2128348T3 (es) Obtencion de composiciones para el tratamiento de alteraciones de la proliferacion celular.
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
ATE274920T1 (de) Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen
ATE101519T1 (de) Verwendung von gestoden zur herstellung von arzneimitteln.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 546096

Country of ref document: ES